>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

CompanyHeadlineTime (ET)
POETFROSEN, GLOBAL INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - POET05/22 17:32
BTGOFBT Group plc (BTGOF) Q4 2026 Earnings Call Transcript05/22 17:30
CHELFChampion Electric Announces Closing of Debt Settlement05/22 17:30
NTGNTG Clarity to Announce First Quarter Financial Results on May 27, 2026 with Earnings Call to Follow05/22 17:28
EWQEWQ: France An Excellent Diversifier, Here's Why05/22 17:27
IBRXImmunityBio 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ImmunityBio, Inc. - IBRX05/22 17:25
SMCISuper Micro Computer, Inc. Notice of May 26, 2026 Application Deadline for Class Action Lawsuits - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline05/22 17:24
CFRHFCompagnie Financière Richemont SA (CFRUY) Q4 2026 Earnings Call Transcript05/22 17:20
DHSDHS: Defensive Yield At The Expense Of Innovation And Growth05/22 17:20
P-SPACSpaceX Faces A Crucial Launch Test Ahead Of Its IPO05/22 17:20
SRADSportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC05/22 17:20
LION3 Top-Rated Stocks to Buy After Crushing EPS Expectations: LION, KEYS, ROST05/22 17:16
BZAIRosen Law Firm Encourages Blaize Holdings, Inc. Investors to Inquire About Securities Class Action Investigation - BZAI05/22 17:15
IMMXImmix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock05/22 17:15
IOVAIovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)05/22 17:15
KNRXKNOREX Receives Notification from NYSE American Regarding Delayed Annual Report Filing05/22 17:15
AAAUGold weakens as U.S.-Iran talks keep oil, rates in focus - Kitco PM Report05/22 17:14
TLSATiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI05/22 17:06
GOOGAlphabet and NVIDIA: The Biggest Mag 7 Winners This Earnings Season05/22 17:06

Market News ×
Loading news…